Patents by Inventor Manisha P DESAI

Manisha P DESAI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF USING CTLA4Ig SUBCUTANEOUS FORMULATIONS
    Publication number: 20230277672
    Abstract: The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous(SC) for treating immune system diseases and tolerance induction.
    Type: Application
    Filed: November 3, 2022
    Publication date: September 7, 2023
    Inventors: Manisha P Desai, Charles E. Dahlheim, Sunita Borsadia, Vijay H. Naringrekar, Rajesh Babulal Gandhi, Manoj Nerurkar
  • METHODS OF USING CTLA4Ig SUBCUTANEOUS FORMULATIONS
    Publication number: 20200230242
    Abstract: The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.
    Type: Application
    Filed: March 24, 2020
    Publication date: July 23, 2020
    Inventors: Manisha P. DESAI, Charles E. Dahlheim, Sunita Borsadia, Vijay H. Naringrekar, Rajesh Babulal Gandhi, Manoj Nerurkar
  • Stable subcutaneous protein formulations and uses thereof
    Patent number: 10265401
    Abstract: The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.
    Type: Grant
    Filed: March 10, 2016
    Date of Patent: April 23, 2019
    Assignee: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Manisha P Desai, Charles E Dahlheim, Sunita Borsadia, Vijay H Naringrekar, Rajesh Babulal Gandhi, Manoj Nerurkar
  • STABLE SUBCUTANEOUS PROTEIN FORMULATIONS AND USES THEREOF
    Publication number: 20180360965
    Abstract: The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.
    Type: Application
    Filed: September 4, 2018
    Publication date: December 20, 2018
    Inventors: Manisha P. Desai, Charles E. Dahlheim, Sunita Borsadia, Vijay H Naringrekar, Rajesh Babulal Gandhi, Manoj Nerurkar
  • STABLE SUBCUTANEOUS PROTEIN FORMULATIONS AND USES THEREOF
    Publication number: 20160263223
    Abstract: The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.
    Type: Application
    Filed: March 10, 2016
    Publication date: September 15, 2016
    Inventors: Manisha P DESAI, Charles E Dahlheim, Sunita Borsadia, Vijay H Naringrekar, Rajesh Babulal Gandhi, Manoj Nerurkar